Pharmacy Technician’s Letter addresses the issues facing pharmacy technicians. For example: What is Vibativ (telavancin)? How does Vibativ work and what class of antibiotics does it belong to? What are the side effects, drug interactions, and cost of Vibativ? When will Vibativ become available? How does Vibativ compare to other antibiotic treatments available for complicated skin infections? What is Vibativ’s place in therapy? How is Vibativ given to patients? How does it compare to other treatments for MRSA? What’s the evidence for using vanco along with other antibiotics for MRSA? Should we recommend against this?

For answers see our article: new IV antibiotic for methicillin-resistant Staph aureus (MRSA), Vibativ (vy-BA-tiv)

	Login if you are a current subscriber to Pharmacy Technician's Letter.
	Subscribe now to get instant access and the answers you need.

Additional information is available in our Detail-Document:
	New Drug: Vibativ (Telavancin)